Form 990 for tax year 2022

Totals

Total revenue

$16,078,688

Total expenses

$19,046,321

Contributions and grants received

$2,694,430

Grants paid

$1,257,571

Program service revenue

$11,036,015

Investment income

$845,711

Other revenue

$1,502,532

Total assets, end of year

$34,254,767

Total liabilities, end of year

$5,246,696

Net assets or fund balances, end of year

$29,008,071

Program services expenses (Part IX)

$16,899,918

Management and general expenses

$2,080,072

Fundraising expenses

$66,331

Program service expenses (Part III)

$16,899,918

Program services were 88.7% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Mission and programs · 2022

• MEETINGS AND EDUCATION, INCLUDING THE ANNUAL MEETING: THE ASSOCIATION'S EDUCATIONAL PROGRAM ENABLES THE DISSEMINATION OF NEW TECHNIQUES AND ADVANCES IN EXISTING KNOWLEDGE AND PROCEDURES TO PHYSICIANS AND OTHER HEALTHCARE PROVIDERS VIA FACE-TO-FACE MEETINGS AND ONLINE LEARNING. THE PROGRAM ALSO PROVIDES REGULAR OPPORTUNITIES FOR THESE PROVIDERS TO REVIEW BASIC, TRANSLATIONAL AND CLINICAL TOPICS IN THEIR SPECIALTY TO PROMOTE THE ADVANCEMENT OF PATIENT CARE AND FOSTER NEW RESEARCH. THE LIVER MEETING, THE ASSOCIATION'S ANNUAL MEETING, OFFERS THE LATEST IN LIVER DISEASE TREATMENT OUTCOMES. ATTENDEES PARTICIPATE IN PLENARY, PARALLEL AND POSTER SESSIONS, STATE-OF-THE-ART LECTURES, EARLY MORNING WORKSHOPS, MEET-THE-PROFESSOR SESSIONS, SPECIALTY COURSES, SPECIAL INTEREST GROUP PROGRAMMING AND SCIENTIFIC EXHIBITS TO EXCHANGE THE LATEST LIVER DISEASE RESEARCH, DISCUSS TREATMENT OUTCOMES, AND INTERACT WITH COLLEAGUES. THE ASSOCIATION HOLDS SMALL STAND-ALONE MEETINGS SUCH AS THE EMERGING TOPIC AND ENDPOINT CONFERENCES, CO-SPONSORS DIGESTIVE DISEASE WEEK, AND COLLABORATES WITH DOMESTIC AND INTERNATIONAL MEDICAL SOCIETIES, GOVERNMENT ENTITIES AND/OR OTHER NONPROFIT ORGANIZATIONS ON MUTUAL EDUCATIONAL PROGRAMMING IN HEPATOLOGY.AASLD'S ONLINE LEARNING OFFERINGS INCLUDE REGULAR WEBINARS ORGANIZED PRIMARILY BY THE ASSOCIATION'S SPECIAL INTEREST GROUPS ON VERY FOCUSED TOPICS THAT ARE RECORDED AND OFFERED ON-DEMAND THROUGH LIVERLEARNING, AASLD'S OFFICIAL E-LEARNING PORTAL. LIVERLEARNING IS AN ONLINEEDUCATIONAL REPOSITORY THAT ORGANIZES DIGITAL CONTENT FROM AASLD MEETINGS AND OTHER EDUCATIONAL OFFERINGS SUCH AS PRACTICE GUIDELINES, SLIDE SET COMPILATIONS AND COURSE HANDOUTS.AASLD IS ACCREDITED BY THE ACCREDITATION COUNCIL FOR CONTINUING MEDICAL EDUCATION (ACCME) TO OFFER AMA PRA CATEGORY 1 CREDIT. IN ADDITION, AASLD OFFERS MAINTENANCE OF CERTIFICATION (MOC) POINTS WHICH ARE AWARDED BASED ON THE SUCCESSFUL COMPLETION OF A CME PROGRAM FOR WHICH MOC IS ALSO OFFERED. MOC IS ULTIMATELY GRANTED BY THE AMERICAN BOARD OF INTERNAL MEDICINE OR AMERICAN BOARD OF PEDIATRICS.

  Expenses $8,292,282 · Grants $10,740 · Revenue $8,287,749

• PUBLICATIONS: THE ASSOCIATION'S PUBLICATIONS PROGRAM INCLUDES FOUR MEDICAL JOURNALS. "HEPATOLOGY", THE OFFICIAL JOURNAL OF THE ASSOCIATION, AND "LIVER TRANSPLANTATION" PROVIDE PEER-REVIEWED RESEARCH ON THE LIVER AND BILIARY TRACT AND THEIR DISEASES. "LIVER TRANSPLANTATION", A SPECIALTY JOURNAL, PUBLISHES STATE-OF-THE-ART INFORMATION ON LIVER TRANSPLANTATION. "CLINICAL LIVER DISEASE" (CLD) IS AN ONLINE EDUCATIONAL JOURNAL THAT ADDRESSES TREATMENT ISSUES FACED BY HEPATOLOGISTS AND NONHEPATOLOGISTS WHEN SEEING PATIENTS WITH LIVER DISEASE. "HEPATOLOGY COMMUNICATIONS" IS A PEER-REVIEWED, ONLINE-ONLY OPEN ACCESS JOURNAL FOR FAST DISSEMINATION OF HIGH QUALITY BASIC, TRANSLATIONAL, AND CLINICAL RESEARCH IN HEPATOLOGY.PRACTICE RESOURCES: AASLD'S PRACTICE RESOURCES PROGRAM INCLUDES (1) PRACTICE GUIDELINES (2) PRACTICE QUALITY METRICS AND (3) THE CIRRHOSIS QUALITY COLLABORATIVE. (1) AASLD PRACTICE GUIDELINES: AASLD DEVELOPS CLINICAL PRACTICEGUIDELINES WHICH INCLUDE RECOMMENDATIONS THAT ARE SUPPORTED BY A HIGH LEVEL OF SCIENTIFIC EVIDENCE TO ASSIST PRACTITIONER AND PATIENT DECISIONS FOR APPROPRIATE HEALTH CARE RELATED TO SPECIFIC CLINICAL CIRCUMSTANCES. (2) PRACTICE QUALITY METRICS: AASLD DEVELOPS PERFORMANCE MEASURES THAT SERVE AS METRICS TO EVALUATE QUALITY OF CARE PROVIDED TO PATIENTS WITH LIVER DISEASES, FROM BOTH THE PROVIDER AND PATIENT PERSPECTIVE (3) CIRRHOSIS QUALITY COLLABORATIVE (CQC) IS A MULTI-SITE DATA REGISTRY AND LEARNING HEALTH NETWORK, RE-LANCHED IN COLLABORATION WITH TARGET RWE, AIMED AT BRIDGING THE GAPS BETWEEN BEST PRACTICE AND CURRENT PRACTICE TO TREAT CIRRHOSIS BY COMBINING QUALITY IMPROVEMENT AND RESEARCH TO DELIVER REAL WORLD DATA AND EVIDENCE THAT WILL IMPROVE PATIENT CARE AND TREATMENT OUTCOMES.CLINICAL AND PUBLIC POLICIES: AASLD CONDUCTS A PUBLIC AND CLINICAL POLICY PROGRAM, WHICH IS SUPERVISED BY THE PUBLIC POLICY COMMITTEE. IT HOLDS TWO EVENTS EACH YEAR: LIVER CAPITOL HILL DAY AND FEDERAL AGENCY DAY. IN THE FORMER, AASLD PARTNERS WITH PATIENT ADVOCACY ORGANIZATIONS TO EDUCATE CONGRESSIONAL LEGISLATORS AND STAFF ON ISSUES RELATED TO LIVER DISEASE RESEARCH AND PATIENT CARE. IN THE LATTER, AASLD DISCUSSES WITH KEY FEDERAL AGENCY PARTNERS WAYS IN WHICH AASLD CAN INFORM THE SCIENTIFIC COMMUNITY OF FEDERAL RESEARCH PRIORITIES. AASLD KEEPS ITS MEMBERS INFORMED OF LEGISLATIVE AND AGENCY DECISIONS THAT AFFECT HEPATOLOGY, AND ENCOURAGES THEM TO REMAIN INVOLVED IN PUBLIC POLICY ISSUES.

  Expenses $5,901,130 · Grants $1,193,311 · Revenue $965,280

• MEMBERSHIP & MENTORSHIP: AASLD'S MEMBERSHIP ENCOMPASSES ALL PROFESSIONALS DEDICATED TO HEPATOBILIARY DISCOVERIES AND PATIENT CARE. AASLD'S MEMBERS INCLUDE MORE THAN 5,500 DOMESTIC AND INTERNATIONAL PHYSICIANS, SCIENTISTS, HEPATOLOGISTS, SURGEONS, PATHOLOGISTS, AND ALLIED HEALTH PROFESSIONALS WHOSE PRACTICE OR RESEARCH INVOLVES THE FUNCTIONING AND DISORDERS OF THE LIVER AND BILIARY TRACT. THE AASLD MENTORSHIP PROGRAM IS DESIGNED TO PROMOTE THE STUDY OF HEPATOLOGY AMONG MEDICAL, SURGICAL, AND PEDIATRIC RESIDENTS, FELLOWS AND EARLY CAREER PROFESSIONALS WHO HAVE THE POTENTIAL FOR OR IS ALREADY IN A CAREER IN ACADEMIC MEDICINE. MEMBERS SERVE AS MENTORS TO THESE PROFESSIONALS, ENSURING THE CONTINUING AVAILABILITY OF KNOWLEDGEABLE, SKILLED, AND WELL-TRAINED HEPATOLOGISTS.WEBSITE: AASLD MAINTAINS A WEBSITE ALLOWING MEMBERS, SCIENTISTS, PHYSICIANS, ALLIED HEALTH PROFESSIONALS, AND OTHER VISITORS TO NAVIGATE AND FIND INFORMATION ABOUT THEIR AREAS OF INTEREST. (SITE VISITORS TOTAL GREATER THAN 450,000 ANNUALLY).COMMUNICATIONS: INCLUDES AASLD E-NEWS, WHICH IS PUBLISHED EVERY OTHER WEEK FOR THE AASLD MEMBERSHIP. ALSO INCLUDES MEDIA RELATIONS SURROUNDING RESEARCH PRESENTED AT THE ANNUAL MEETING, AS WELL AS MAJOR MILESTONES THROUGHOUT THE YEAR RELATED TO THE SOCIETY. AASLD DISSEMINATES INFORMATION ABOUT ADVANCES MADE IN THE TREATMENT OF PATIENTS WITH LIVER DISEASE AND POLICY DECISIONS THAT REFLECT CLINICIANS, RESEARCHERS, AND PATIENTS.

  Expenses $2,706,506 · Grants $53,520 · Revenue $1,782,986

As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.

Schedule J

Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.

Grants on this return

• AMERICAN ASSOCIATION FOR THE STUDY OF LIVER DISEASES FOUNDATION

  $1,169,900

  TO INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND IN THE PEOPLE WHO STUDY AND TREAT LIVER DISEASE; TO PROVIDE FUNDING FOR EMERGING LIVER SCHOLAR TRAVEL STIPENDS; PROVIDE FUNDING FOR TRAVEL AWARDS EXPENSES

Related organizations on this return

Schedule R Part II: tax-exempt organizations related to the filer by control. It does not record shared board members or money.

• AASLD FOUNDATION

  501(C)(3) · INVEST IN INNOVATIVE HEPATOLOGY RESEARCH AND PEOPLE WHO STUDY LIVER DISEASE · VA · controlled entity

  Directly controlled by AASLD

Provenance

Return type

form_990

Tax year

2022

Filed

13 March 2024

IRS schema version

2022v5.0

Source object

202430739349301303

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.